Publicaciones (54) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. Activity measurement of hydantoin racemase enzyme: A key for the production of optically pure D-amino acids

    D-Amino Acids: A New Frontier in Amino Acid and Protein Research - Practical Methods and Protocols (Nova Science Publishers, Inc.), pp. 573-577

  2. Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms

    Tissue Antigens

  3. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours

    Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226

  4. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus

    Tissue Antigens, Vol. 70, Núm. 3, pp. 233-237

  5. Asporin repeat polymorphism in rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 1, pp. 118-120

  6. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 9, pp. 3080-3086

  7. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease

    Gut

  8. CD209 in inflammatory bowel disease: A case-control study in the Spanish population

    BMC Medical Genetics, Vol. 8

  9. Characterization of human control region sequences for Spanish individuals in a forensic mtDNA data set

    Legal Medicine, Vol. 9, Núm. 6, pp. 293-304

  10. Consumption of caprine milk improves metabolism of calcium and phosphorus in rats with nutritional ferropenic anaemia

    International Dairy Journal, Vol. 17, Núm. 4, pp. 412-419

  11. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis

    Rheumatology, Vol. 46, Núm. 3, pp. 431-434

  12. Control of virus infection by tumour suppressors

    Carcinogenesis, Vol. 28, Núm. 6, pp. 1140-1144

  13. Different mechanisms can lead to the same altered HLA class I phenotype in tumors

    Tissue Antigens

  14. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

    BMC Cancer, Vol. 7

  15. Distribution of HLA class I altered phenotypes in 92 melanoma cell lines

    TISSUE ANTIGENS

  16. Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy

    Annals of the Rheumatic Diseases

  17. Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas

    Blood, Vol. 110, Núm. 9, pp. 3345-3351

  18. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)

    British Journal of Pharmacology, Vol. 150, Núm. 6, pp. 808-815

  19. HLA class I antigen expression and tumor immune escape

    13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY

  20. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination

    Cancer Immunology, Immunotherapy, Vol. 56, Núm. 5, pp. 709-717